|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 165,900.00 KRW | -4.16% |
|
-2.58% | -3.76% |
| 06-19 | South Korean Shares Snap Six-Day Winning Streak on Profit-Booking | MT |
| 06-18 | Celltrion's EU Clinical Trial Nod for Crohn's Disease Drug Lapses | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Biotechnology & Medical Research
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 23.77B | |||||
| 46.2B | |||||
| 38.71B | - | - | - | - | - |
| 31.9B | |||||
| 31.12B | |||||
| 16.2B | - |
- Stock Market
- Stocks
- A068270 Stock
- Charts Celltrion, Inc.
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
